178 related articles for article (PubMed ID: 24991634)
1. A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia.
Vilapurathu JK; Rajarajan S
J Res Pharm Pract; 2014 Jan; 3(1):34-6. PubMed ID: 24991634
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
[TBL] [Abstract][Full Text] [Related]
3. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.
Mohmand HK; Issa D; Ahmad Z; Cappuccio JD; Kouides RW; Sterns RH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1110-7. PubMed ID: 17913972
[TBL] [Abstract][Full Text] [Related]
4. Current treatment practice and outcomes. Report of the hyponatremia registry.
Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients.
Tosh P; Rajan S; Kadapamannil D; Joseph N; Kumar L
Indian J Anaesth; 2017 Dec; 61(12):996-1001. PubMed ID: 29307906
[TBL] [Abstract][Full Text] [Related]
6. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Vaghasiya RP; DeVita MV; Michelis MF
Int Urol Nephrol; 2012 Jun; 44(3):865-71. PubMed ID: 21607553
[TBL] [Abstract][Full Text] [Related]
8. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Rudolf D; Salahudeen A; Verbalis J; Grohé C
Support Care Cancer; 2017 Jul; 25(7):2275-2283. PubMed ID: 28255808
[TBL] [Abstract][Full Text] [Related]
9. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry).
Dunlap ME; Hauptman PJ; Amin AN; Chase SL; Chiodo JA; Chiong JR; Dasta JF
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775063
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
11. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
Cyr PL; Slawsky KA; Olchanski N; Krasa HB; Goss TF; Zimmer C; Hauptman PJ
Am J Health Syst Pharm; 2011 Feb; 68(4):328-33. PubMed ID: 21289328
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia management among patients admitted to tertiary hospital: A retrospective evaluation.
Zurnuq S; Aljurfi M; Albekery M; Shawaqfeh MS; Elmubark A; Vasudevan S; Alharbi S; Alkatheri M; Albekairy AM; Al Katheri AA
SAGE Open Med; 2022; 10():20503121221095333. PubMed ID: 35509952
[TBL] [Abstract][Full Text] [Related]
13. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
14. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.
Ayus JC; Olivero JJ; Frommer JP
Am J Med; 1982 Jan; 72(1):43-8. PubMed ID: 7058821
[TBL] [Abstract][Full Text] [Related]
15. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
16. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
[TBL] [Abstract][Full Text] [Related]
17. Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.
Umbrello M; Mantovani ES; Formenti P; Casiraghi C; Ottolina D; Taverna M; Pezzi A; Mistraletti G; Iapichino G
Ann Intensive Care; 2016 Dec; 6(1):1. PubMed ID: 26728593
[TBL] [Abstract][Full Text] [Related]
18. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.
Woo CH; Rao VA; Sheridan W; Flint AC
Neurocrit Care; 2009; 11(2):228-34. PubMed ID: 19533046
[TBL] [Abstract][Full Text] [Related]
20. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
Gankam Kengne F; Couturier BS; Soupart A; Decaux G
Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
